Peterson GM - Search Results

1

Drug-related problems identified in medication reviews by Australian pharmacists.

Stafford AC, Tenni PC, Peterson GM, Jackson SL, Hejlesen A, Villesen C, Rasmussen M. Stafford AC, et al. Among authors: peterson gm. Pharm World Sci. 2009 Apr;31(2):216-23. doi: 10.1007/s11096-009-9287-y. Epub 2009 Feb 26. Pharm World Sci. 2009. PMID: 19242818

2

Drug-related admissions to an Australian hospital.

Stanton LA, Peterson GM, Rumble RH, Cooper GM, Polack AE. Stanton LA, et al. Among authors: peterson gm. J Clin Pharm Ther. 1994 Dec;19(6):341-7. doi: 10.1111/j.1365-2710.1994.tb00691.x. J Clin Pharm Ther. 1994. PMID: 7876364

3

Programme to improve the use of drugs in older people and involve general practitioners in community education.

Reeve JF, Peterson GM, Rumble RH, Jaffrey R. Reeve JF, et al. Among authors: peterson gm. J Clin Pharm Ther. 1999 Aug;24(4):289-97. doi: 10.1046/j.1365-2710.1999.00228.x. J Clin Pharm Ther. 1999. PMID: 10475987

4

Long term anticoagulation or antiplatelet treatment. Garbage in equals garbage out.

Peterson G, Jackson S. Peterson G, et al. BMJ. 2001 Jul 28;323(7306):234; author reply 235-6. BMJ. 2001. PMID: 11496888 No abstract available.

5

Outcomes in the management of atrial fibrillation: clinical trial results can apply in practice.

Jackson SL, Peterson GM, Vial JH, Daud R, Ang SY. Jackson SL, et al. Among authors: peterson gm. Intern Med J. 2001 Aug;31(6):329-36. doi: 10.1046/j.1445-5994.2001.00071.x. Intern Med J. 2001. PMID: 11529586

6

Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention.

Peterson GM, Boom K, Jackson SL, Vial JH. Peterson GM, et al. Intern Med J. 2002 Jan-Feb;32(1-2):15-23. Intern Med J. 2002. PMID: 11783668

7

Cost-effectiveness of newer antiplatelet drugs.

Peterson GM, Jackson SL. Peterson GM, et al. Arch Intern Med. 2003 Nov 10;163(20):2533-4; author reply 2534. doi: 10.1001/archinte.163.20.2533-b. Arch Intern Med. 2003. PMID: 14609794 No abstract available.

8

Accuracy, reproducibility and clinical utility of the CoaguChek S portable international normalized ratio monitor in an outpatient anticoagulation clinic.

Jackson SL, Bereznicki LR, Peterson GM, Marsden KA, Jupe DM, Tegg E, Vial JH, Kimber RI. Jackson SL, et al. Among authors: peterson gm. Clin Lab Haematol. 2004 Feb;26(1):49-55. doi: 10.1111/j.0141-9854.2003.00578.x. Clin Lab Haematol. 2004. PMID: 14738438

9

Impact of pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapy.

Peterson GM, Fitzmaurice KD, Naunton M, Vial JH, Stewart K, Krum H. Peterson GM, et al. J Clin Pharm Ther. 2004 Feb;29(1):23-30. doi: 10.1046/j.1365-2710.2003.00532.x. J Clin Pharm Ther. 2004. PMID: 14748894 Clinical Trial.

10

Randomized trial of warfarin nomograms.

Peterson GM, Jackson SL. Peterson GM, et al. Ann Intern Med. 2004 Mar 16;140(6):488; author reply 491-2. doi: 10.7326/0003-4819-140-6-200403160-00022. Ann Intern Med. 2004. PMID: 15023720 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

433 results

Search Page

Filters